Announced
Merck to acquire an Ireland vaccine facility from WuXi Biologics for $500m.
Synopsis
Merck, a global pharmaceutical and chemicals company, agreed to acquire an Ireland vaccine facility from WuXi Biologics, a global open-access biologics technology platform, for $500m.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2025 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.